Buspirone

CHEBI:CHEBI_3223

Definition

An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Chemical Information

Molecular Formula
C21H31N5O2
Molecular Mass
385.504
Charge
0
SMILES
C=1N=C(N=CC1)N2CCN(CC2)CCCCN3C(CC4(CC3=O)CCCC4)=O
InChI
InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2
InChIKey
QWCRAEMEVRGPNT-UHFFFAOYSA-N

Alternative Names

  • 8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione
  • 8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione
  • buspirona
  • buspirone
  • Buspirone
  • buspironum

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

oboInOwl#hasDbXref
Wikipedia:Buspirone
DRON_00010000
1827
core#notation
CHEBI:3223

Additional References

Wikipedia:Buspirone

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

has_treatment
http://purl.obolibrary.org/obo/DOID_0111831
owl#someValuesFrom
t1022895
labeler_name
Medilux Laboratories Private Limited
marketing_start_date
19941021
package_ndc
71335-1605-4
package_description
60 TABLET in 1 BOTTLE, PLASTIC (68788-8681-6)
product_ndc
14593-948
oboInOwl#hasOBONamespace
chebi_ontology
oboInOwl#hasDbXref
Wikipedia:Buspirone
DRON_00010000
1827
oboInOwl#id
CHEBI:3223
generic_name
Buspirone Hcl
brand_name
Buspirone Hcl
brand_name_base
Buspirone Hcl
RO_0000087
http://purl.obolibrary.org/obo/CHEBI_76779
oboInOwl#inSubset
http://purl.obolibrary.org/obo/chebi#3_STAR
chebi#is_conjugate_base_of
http://purl.obolibrary.org/obo/CHEBI_132102
listing_expiration_date
20241231
spl_id
9f391541-688d-4c79-b89c-d1e22f77b859
package_marketing_start_date
20240505
product_type
BULK INGREDIENT
dosage_form
POWDER
marketing_category
BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
application_number
ANDA074253
rxcui
866111
manufacturer_name
Nivagen Pharmaceuticals Inc.
unii
207LT9J9OC
spl_set_id
75b1ae3f-e926-4555-a0e9-50323fc66cb2
core#notation
CHEBI:3223
active_ingredient_strength
15 mg/1
upc
0382804039609
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
active_ingredient_name
BUSPIRONE
route
ORAL
rdf-schema#domain
https://w3id.org/def/predibionto#has_side_effect5791
chebi#is_conjugate_acid_of
http://purl.obolibrary.org/obo/CHEBI_132102
owl#annotatedSource
t187207